Clinical Trial Update: Population Based Evaluation of the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases

View source ↗

Summary

A completed population-based evaluation investigates how TNFα antagonists are used in pregnant women with inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)
• ENBREL (etanercept)
• Humira (adalimumab)
• Remicade (infliximab)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Inflammatory Bowel Diseases | Status: COMPLETED